Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RECOVER: Quetiapine XR vs Risperidone in Schizophrenia
NCT00600756Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of quetiapine (extended-release tablet, brand name: Bipresso) in schizophrenia, sponsored by AstraZeneca. Started Jan 2008; status: completed.
02
Drugs
quetiapine (extended-release tablet, brand name: Bipresso)
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00600756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00600756.